Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective ; volume:24 ; number:1 ; day:21 ; month:8 ; year:2024 ; pages:1-10 ; date:12.2024
BMC public health ; 24, Heft 1 (21.8.2024), 1-10, 12.2024
- Creator
-
Meng, Wenxin
Yang, Shudi
Wang, Zhangke
Xie, Jinping
Jiang, Rong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12889-024-19786-y
- URN
-
urn:nbn:de:101:1-2411072106386.312022427854
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Meng, Wenxin
- Yang, Shudi
- Wang, Zhangke
- Xie, Jinping
- Jiang, Rong
- SpringerLink (Online service)
Other Objects (12)
International comparison of the factors influencing reimbursement of targeted anti-cancer drugs
Imaging manifestations of unusual side effects of new anticancer medications
MISSION FIELD REIMBURSEMENT FILE
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: Evidence from an online experiment
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
Optimizing Patient Education of Oncology Medications: A Patient Perspective
The implementation of DRG-based hospital reimbursement in Switzerland: A population-based perspective
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
MEDICAL BILLS CLAIM FOR REIMBURSEMENT
Deposit Insurance: Reimbursement of Depositors
Availability and affordability of anticancer medicines at cancer treating hospitals in Rwanda
Unmet needs in EGFR exon 20 insertion mutations in Central and Eastern Europe: reimbursement, diagnostic procedures, and treatment availability
International comparison of the factors influencing reimbursement of targeted anti-cancer drugs
Imaging manifestations of unusual side effects of new anticancer medications
MISSION FIELD REIMBURSEMENT FILE
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: Evidence from an online experiment
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
Optimizing Patient Education of Oncology Medications: A Patient Perspective
The implementation of DRG-based hospital reimbursement in Switzerland: A population-based perspective
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
MEDICAL BILLS CLAIM FOR REIMBURSEMENT
Deposit Insurance: Reimbursement of Depositors
Availability and affordability of anticancer medicines at cancer treating hospitals in Rwanda
Unmet needs in EGFR exon 20 insertion mutations in Central and Eastern Europe: reimbursement, diagnostic procedures, and treatment availability
International comparison of the factors influencing reimbursement of targeted anti-cancer drugs
Imaging manifestations of unusual side effects of new anticancer medications
MISSION FIELD REIMBURSEMENT FILE
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: Evidence from an online experiment
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
Optimizing Patient Education of Oncology Medications: A Patient Perspective
The implementation of DRG-based hospital reimbursement in Switzerland: A population-based perspective
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
MEDICAL BILLS CLAIM FOR REIMBURSEMENT
Deposit Insurance: Reimbursement of Depositors
Availability and affordability of anticancer medicines at cancer treating hospitals in Rwanda